| Bioactivity | 2-Methylamino-N6-methyladenosine is a purine nucleoside analogue. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1]. |
| Name | 2-Methylamino-N6-methyladenosine |
| CAS | 28360-91-0 |
| Formula | C12H18N6O4 |
| Molar Mass | 310.31 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Robak T, Robak P. Purine nucleoside analogs in the treatment of rarer chronic lymphoid leukemias. Curr Pharm Des. 2012;18(23):3373-88. |
2-Methylamino-N6-methyladenosine
CAS: 28360-91-0 F: C12H18N6O4 W: 310.31
2-Methylamino-N6-methyladenosine is a purine nucleoside analogue. Purine nucleoside analogs have broad antitumor activit
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.